Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

POST-PERICARDIOTOMY AND RELATED SYNDROMES.

A listing of research in the cardiovascular field·2014
Same author

Reasons for higher in-hospital mortality >24 hours after percutaneous transluminal coronary angioplasty in women compared with men.

The American journal of cardiology·2001
Same author

Urgent coronary bypass surgery for failed percutaneous coronary intervention in the stent era: Is backup still necessary?

American heart journal·2001
Same author

Automatically optimizing pacing output: an excellent idea, but with potentially lethal pitfalls.

Pacing and clinical electrophysiology : PACE·2001
Same author

Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group.

Journal of the American College of Cardiology·2001
Same author

Effects of physiologic pacing versus ventricular pacing.

The New England journal of medicine·2001

Related Experiment Video

Updated: Jun 21, 2026

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
07:09

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise

Published on: February 20, 2017

Left ventricular wall motion response to intravenous propranolol.

S J Shubrooks, L M Zir, R E Dinsmore

    Circulation
    |July 11, 1975
    PubMed
    Summary

    Intravenous propranolol did not significantly alter left ventricular wall motion in patients with coronary artery disease. Even at higher doses, effects on cardiac index were minimal, with no substantial changes in regional contractility observed.

    More Related Videos

    Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis
    08:05

    Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis

    Published on: May 19, 2021

    Functional Assessment of the Donor Heart During Ex Situ Perfusion: Insights from Pressure-Volume Loops and Surface Echocardiography
    08:21

    Functional Assessment of the Donor Heart During Ex Situ Perfusion: Insights from Pressure-Volume Loops and Surface Echocardiography

    Published on: October 11, 2022

    Related Experiment Videos

    Last Updated: Jun 21, 2026

    Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
    07:09

    Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise

    Published on: February 20, 2017

    Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis
    08:05

    Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis

    Published on: May 19, 2021

    Functional Assessment of the Donor Heart During Ex Situ Perfusion: Insights from Pressure-Volume Loops and Surface Echocardiography
    08:21

    Functional Assessment of the Donor Heart During Ex Situ Perfusion: Insights from Pressure-Volume Loops and Surface Echocardiography

    Published on: October 11, 2022

    Area of Science:

    • Cardiology
    • Pharmacology
    • Cardiovascular Physiology

    Background:

    • Coronary artery disease (CAD) can impair left ventricular (LV) function.
    • Beta-blockers like propranolol are used to manage cardiovascular conditions.
    • The impact of intravenous propranolol on LV wall motion in CAD patients requires clarification.

    Purpose of the Study:

    • To investigate the effects of intravenous propranolol on LV wall motion and hemodynamics.
    • To assess changes in patients with and without coronary artery disease.
    • To determine dose-dependent effects of propranolol on cardiac function.

    Main Methods:

    • 16 patients (12 with CAD, 4 without) received either 0.10 mg/kg or 0.15 mg/kg intravenous propranolol.
    • Atrial pacing maintained a constant heart rate.
    • Left ventricular angiograms were performed pre- and post-propranolol administration.

    Main Results:

    • Propranolol did not significantly alter LV systolic or diastolic pressures at either dose.
    • Cardiac index decreased significantly only with the higher propranolol dose (0.15 mg/kg).
    • No significant changes in regional LV contractility were observed in CAD patients, with minor exceptions.

    Conclusions:

    • Intravenous propranolol, even in substantial doses, does not significantly impair left ventricular wall motion in patients with coronary artery disease.
    • Propranolol's hemodynamic effects, including cardiac index reduction, are dose-dependent.
    • Further research may be needed to understand propranolol's effects in non-CAD patients with chest pain.